[5-(2,4-difluorophenyl)isoxazol-3-yl]methanol, 95.0%, 500mg

(3aS,4S,6R,6aR)-4-(Iodomethyl)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole, 95+%, 1g

3-Bromo-1H-indazole-7-carbonitrile, 95.0%, 5g

2-methoxy-6-methylnicotinonitrile, 95.0%, 5g

9-Oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 97%, 5g

1,1,1-Trifluoro-n,n-dimethylmethanesulfonamide, 95%, 25g

(8-Chloro-1-naphthylthio)acetic Acid>95.0%(T)5g

2-(Chloromethyl)-3-(trifluoromethyl)pyridine, 98%, 250mg

potassium 1,3-benzothiazole-2-carboxylate, 95.0%, 1g

Lithium fluoride, min. 98.5%, 250 g, plastic packaging.

PYRAZOLO[1,5-A]PYRIDIN-5-OL, 95.0%, 250mg

2-[3,5-Bis(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)5g

3,3,4,4,5,5,5-Heptafluoropentan-2-ol, 97.0%, 5g